相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats
Yoshikazu Fujimori et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level
Kenji Katsuno et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Familial renal glucosuria:: SLC5A2 mutation analysis and evidence of salt-wasting
J Calado et al.
KIDNEY INTERNATIONAL (2006)
Sodium glucose co-transporter 2 (SGLT2) inhibitors as potential antidiabetic agents
AL Handlon
EXPERT OPINION ON THERAPEUTIC PATENTS (2005)
Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes
JF Gautier et al.
DIABETES & METABOLISM (2005)
Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus
E Selvin et al.
ANNALS OF INTERNAL MEDICINE (2004)
Weight management through lifestyle modification for the prevention and management of type 2 diabetes: Rationale and strategies
S Klein et al.
DIABETES CARE (2004)
Updated review on the benefits of weight loss
J Vidal
INTERNATIONAL JOURNAL OF OBESITY (2002)
Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2)
LP van den Heuvel et al.
HUMAN GENETICS (2002)
Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1
JJ Holst
DIABETES-METABOLISM RESEARCH AND REVIEWS (2002)
Reduced postprandial concentrations of intact biologically active gluccagon-like peptide 1 in type 2 diabetic patients
T Vilsboll et al.
DIABETES (2001)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes
KV Williams et al.
DIABETES OBESITY & METABOLISM (2000)